Mission statement · Company scope
“Our mission is to leverage our unique insights into the chromatin regulatory system to pioneer the discovery, development and commercialization of a new class of therapies that transform the lives of patients suffering from a wide spectrum of diseases with high unmet need.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Problem–solution · Impact
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Plain
- Length
- 43 words · reading grade 22.9
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.60
- Record
- st_db8084321e737a19
- Classification confidence
- 0.69
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-11 · sec_sentence · 10-K · accession 0001628280-26-016814
View filing ↗0 to compareCompare